Clinical update on the diagnosis and treatment of bacterial endocarditis

Comprehensive Therapy

Volumn 33, Issue 4, 2007, Pages 192-207

  Dandache, Patricia ^a   Aronow, Wilbert S ^a   Sakoulas, George ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BACTERICIDE; CEFAZOLIN; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; DAPTOMYCIN; GENTAMICIN; NAFCILLIN; OXACILLIN; PENICILLIN G; PENICILLIN G SODIUM; RIFAMPICIN; SULTAMICILLIN; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL ENDOCARDITIS; COMBINATION CHEMOTHERAPY; DRUG BLOOD LEVEL; ECHOCARDIOGRAPHY; HUMAN; MONOTHERAPY; MORBIDITY; MORTALITY; PATHOGENESIS; REVIEW; STAPHYLOCOCCUS AUREUS;

ANTI-INFECTIVE AGENTS; DISEASE MANAGEMENT; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDOCARDITIS, BACTERIAL; HUMANS;

EID: 36949035794     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12019-007-8020-9     Document Type: Review

References (40)

1. Lerner PI, Wenstein L. Infective endocarditis in the antibiotic era. N Engl J Med 1966;274-99.
2. Moreillon P, Que Y. Infective endocarditis. Lancet 2004;363:139-49.
3. Mandell D. Benett's principles and practice of infectious disease 6th ED p. 975-1022.
4. Abott KC. Agodoa hospitalization for bacterial endocarditis after initiation of chronic dialysis in the United States. Nephron 2002;91:203-9.
5. Hogevik H, Olaison L, Anderson R, Lindberg J. Epidemiologic aspects of infective endocarditis in an urban population: a 5 year prospective study. Medicine (Baltimore) 1995;74:324-9.
6. Zuppiroli A, Rinaldi M, Krane-Fox R, et al. Natural history of mitral valve prolapse. Am J Cardiol 1995;75:1028-31.
7. Strom BL, Abrutyu E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and non oral exposure. Circulation 2000;102:2842-8.
8. Wilson LE, Thomas DL, Astemborki J, Freidman TL, Valhov D. Prospective study of infective endocarditis among injection drug users. J Infect Dis 2002;185:1761-66.
9. Sidhu P, O'kane H, Ali N, et al. Mechanical or bioprostethic valves n the elderly: a 20 year comparison. Ann Thorac Surg 2001;71(5 suppl):S257-60.
10. Arvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Thorac Surg 1988;2:3406.
11. Hecht S, Berger M. Right sided endocarditis in intravenous drug users. Annal Int Med 1992;117:S60-6.
12. Bouzle E, Menasalvas A, Munaez P, Vassalo FJ, del Mar Moreno M. Infective endocarditis: a prospective study at the end of the twentieth century: new predisposing conditions, new etiologic agents and still a high mortality. Medicine (Baltimore) 2001;80:298-307.
13. Mylonakis E, Calderwood S. Infective endocarditis in adults. N Engl J Med 345;18:1318-30.
14. Moreilon P et al. Pathogenesis of streptococcal and staphylococcal endocarditis. Infect Dis Clin N Am 2002;16:297-318.
15. Lowy FD. Staphylococcus aureus infection. N Engl J Med 1998;339:S20-32.
16. Fowler V, Li J, Correg GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia. J Am Coll Cardiol 1997;30:1072-8.
17. Heidenreich PA, Masondi FA, Maini B, et al. Echocardiography in patients with suspected endocarditis: a cost effective analysis. Am J Med 1999;107:198-208.
18. Baddour L, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy and management of complications: statement for health care professional. Circulation 2005;111:e394-434.
19. Durak DT, Luke AS, Bright DK. New criteria for diagnosis of infective endocarditis. Am J Med 1994;96:200-9.
20. Thongaroopar M, Choy J. Is transesophageal echocardiography overused in the diagnosis of infective endocarditis. Am J Cardiol 2005;95:195-297.
21. Mcdermott B et al. The lack of diagnostic value of the indium scan in acute bacterial endocarditis. Am J Med 2004;117:621-3.
22. Framioli PB. Ceftriaxone and outpatient treatment of infective endocarditis. Infect Dis Clin N Am 1993;7:97-115.
23. Bayer A, Bolge A, Tanbert K, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936-48.
24. Pesanti EL, Smith IM. Infective endocarditis with negative blood cultures: an analysis of 52 cases. Am J Med 1979;66:43-50.
25. Van Scoy RE. Culture negative endocarditis. Mayo ClinProc 1982;57:149-54.
26. ACC/AHA 2006 guidelines for management of patients with valvular heart disease. Circulation 2006;114:84-231.
27. Nuerly DL, Perlma PE. Endocarditis: changing trends in epidemiology, clinical and microbiologic spectrum. Post Grad Med 1993;93:241-7.
28. Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-65.
29. Sakoulas G, Moellering Jr RC, Eliopoulos GM. Adaptation of methicillin-resistant Staphylococcus aureus to vancomycin therapy. Clin Infect Dis 2006;42(Suppl 1):S40-50.
30. Megran DW. Enterococcal endocarditis. Clin Infect Dis 1992;15:63-71.
31. Olaison L, Petterson G. Current best practices and guidelines. Indications for surgical intervention in infective endocarditis. Cardiol Clin 2003;21:235-51.
32. Omari B, Shapiro S, Ginzton L, et al. Predictive risk factors for periannular extension of native valve endocarditis: clinical and echocardioraphic analyses. Chest 1989;96:1273-9.
33. Rohman S, Erbel R, George G, et al. Clinical relevance of vegetation localization by transesophageal echocardiogram in infective endocarditis. Eur Heart J 1992;13:446-52.
34. Gillimov AM, Shah RV, Curtis WE, et al. valve replacement in patients with endocarditis and acute neurologic deficit. Ann Thorac Surg 1996;61:1125-30.
35. Matsushita K, Kuriyama Y, Sawada T, et al. Hemorrhagic and ischemic cerebrovascular complications of active infective endocarditis of native valve. Eur Neurol 1992;33:267-74.
36. Crawford M, Durack D. Clinical presentation of infective endocarditis. Cardiol Clin 2003;21:159-66.
37. Lederman M, Sprague L, Wallis R, Ellner J. Duration of fever during treatment of infective endocarditis. Medicine 1992;71(1):52-7.
38. Hoen B, et al. Evaluation of the Duke criteria versus the Beth Israel criteria for the diagnosis of infective endocarditis. Clin Infect Dis 1995;21:905-9.
39. Sakoulas G, Eliopoulos GM, Fowler Jr VG, Moellering Jr RC, Novick RP, Lucindo N, et al. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlate with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother 2005;49:2687-92.
40. Fowler Jr VG, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Cabell CH, et al. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis 2004;190:1140-9.